You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
國際醫學(000516.SZ)下屬醫院幹細胞臨牀研究機構和臨牀研究項目完成備案
格隆匯 11-24 20:11

格隆匯11月24日丨國際醫學(000516.SZ)公佈,近日,按照國家衞健委、國家食藥監總局《幹細胞臨牀研究管理辦法(試行)》的規定,公司下屬西安高新醫院幹細胞臨牀研究機構和“臍帶間充質幹細胞治療糖皮質激素耐藥的慢性廣泛性皮膚移植物抗宿主病的臨牀研究”項目順利完成國家衞健委、國家食藥監總局備案。

幹細胞是一類具有自我複製能力和多向分化潛能的多能細胞,通過誘導可進一步分化為多種功能細胞,為有效修復人體重要組織器官損傷、治療心血管、神經系統、血液系統、代謝性及自身免疫性疾病等提供了新方法,以幹細胞技術為核心的再生醫學,將成為繼藥物治療、手術治療後最具潛能的疾病治療手段之一。

西安高新醫院此次成為陝西省第一家成功完成國家幹細胞臨牀研究機構及幹細胞臨牀研究項目備案的醫院,有助於其幹細胞臨牀研究工作的規範開展和臨牀轉化。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account